Fisher's Pierce Unit Becomes NIH's 'Preferred Vendor' for Protein Profiling
The US National Institutes of Health has chosen Fisher Biosciences' Pierce Biotechnology unit to be its 'preferred vendor' for conducting protein sample analysis, Fisher said this week.
The NIH will use Pierce's SearchLight multiplex-profiling technology to analyze secreted protein expression in samples submitted by the NIH, including the National Cancer Institute, the National Institute of Allergies and Infectious Disease, and other affiliated NIH organizations, according to Fisher.
SearchLight is a multiplex sandwich enzyme-linked immunosorbent assay in a 96-well plate-based array format. Fisher claims it can measure up to 12 secreted proteins simultaneously per well.
Financial details of the arrangement were not discussed.
ForteBio Opens European Outpost in the Netherlands
ForteBio this week announced the opening of a sales and support office in the Netherlands.
ForteBio, based in Menlo Park, Calif., manufactures and markets label-free systems for detecting and analyzing molecular interactions. In particular, its flagship Octet System accelerates the characterization of antibody candidates by generating real-time quantitative and kinetic results, even in crude samples, the company said.
ForteBio said it opened to office to keep up with increased demand for the Octet in Europe. The Netherlands-based sales and support office will be locally managed by TouchDown Biomarketing.
Acolyte and Berthold Tech to Co-Market Cellular Enumeration Technology
Acolyte said this week that it has formed a marketing alliance with Berthold Technologies for its life science products.
Specifically, Berthold, based in Bad Wildbad, Germany, will distribute Acolyte's BacLite RapiTECT enumeration assays in Europe and the US. The BacLite range of products includes RapiTECT Gram Negative for the detection and enumeration of gram-negative bacterial cells; and BacLite RapiTECT Mammalian for mammalian cell enumeration.
Financial terms were not disclosed.